Leerink Partners Raises Incyte (INCY) Estimates Ahead of the Report
Tweet Send to a Friend
Leerink Partners analyst, Michael Schmidt, raised estimates on Incyte (NASDAQ: INCY) ahead of 4Q15 earnings to reflect 1) higher baricitinib ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
